Medication‐resistant epilepsy is associated with a unique gut microbiota signature
Antonella Riva(University of Genoa), Pasquale Striano(Great Ormond Street Hospital), Greta Volpedo(The Ohio State University), Carmen De(University of Naples Federico II), Osman Uğur Sezerman(Kent Hastanesi), Emanuele Cerulli Irelli(Sapienza University of Rome), Emilio Russo(Magna Graecia University), Federico Zara(Istituto Giannina Gaslini), Valentina Biagioli(University of Bologna), Carlo Di Bonaventura(Sapienza University of Rome), Eray Şahin(Kent Hastanesi), Noemi Teresa Catania(University of Genoa), Ganna Balagura(University of Genoa), Isabel Venara(University of Turin), Elisabetta Amadori(Istituto Giannina Gaslini)
Cited by 18
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|249
Microbiota-gut brain axis involvement in neuropsychiatric disorders
|Expert Review of Neurotherapeutics|2019|177
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|151